Skip to main content
Login
Contact
Subscribe
Search form
Search
The Decatur Daily Democrat
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Photos
Videos
Games
Entertainment
Local Guide
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Aptose Biosciences Ord Shs
(NQ:
APTO
)
4.940
USD
-0.030 (-0.60%)
Official Closing Price
/ Updated:
5:51 PM EDT, Aug 10, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
1,020,300
Open
4.990
Bid (Size)
4.900 (1)
Ask (Size)
5.110 (33)
Prev. Close
4.970
Today's Range
4.810 - 5.020
52wk Range
1.820 - 9.250
Shares Outstanding
33,413,073
Dividend Yield
N/A
Performance
YTD
-10.67%
-10.67%
1 Month
-17.53%
-17.53%
3 Month
-41.40%
-41.40%
6 Month
-34.48%
-34.48%
1 Year
+80.95%
+80.95%
Top News
More News
Aptose Biosciences to Present at Canaccord Genuity 40th Annual Growth Conference
August 06, 2020
from
GlobeNewswire News Releases
Aptose Reports Results for the Second Quarter 2020
August 04, 2020
from
GlobeNewswire News Releases
More News
Read More
Aptose to Release Second Quarter Ended June 30, 2020 Financial Results and Hold Conference Call on August 4, 2020
July 21, 2020
from
GlobeNewswire News Releases
Aptose Announces Pricing of Public Offering of Common Shares
July 15, 2020
from
GlobeNewswire News Releases
Aptose Announces Proposed Public Offering of Common Shares
July 15, 2020
from
GlobeNewswire News Releases
Aptose Announces FDA Allowance of IND for Phase 1a/b Study of CG-806 in Acute Myeloid Leukemia
June 29, 2020
from
GlobeNewswire News Releases
Aptose Presents Early Phase 1a/b CG-806 Clinical Findings at the 25th Congress of the European Hematology Association
June 12, 2020
from
GlobeNewswire News Releases
First Week of APTO September 18th Options Trading
July 20, 2020
category
Stocks
from
Market News Video
APTO Crosses Below Key Moving Average Level
July 16, 2020
category
Stocks
from
Market News Video
Why Aptose Biosciences Stock Sank Today
July 16, 2020
category
APTO
,
Market News
from
Motley Fool
7 Stocks Moving In Wednesday's After-Hours Session
July 15, 2020
category
CYTK
,
AZN
,
AA
, and 10 more.
from
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
